The Companion Animal Vaccines report takes into consideration all the market shares and approaches of the major competitors or the key players in the market. The market report highlights the global key manufacturers, to define, describe and analyze the market competition landscape. This report has forecasted compound annual growth rate (CAGR) in % value for specific period that will help ABC industry to take decision based on futuristic chart. The Companion Animal Vaccines market report also identifies significant trends and factors motivating or inhibiting the market growth. This report offers actionable market insights as well as lends a hand to create sustainable and economic business strategies.
Data Bridge Market Research analyses that the companion animal vaccines market is expected to undergo a CAGR of 5.60% during the forecast period. This indicates that the market value, which was USD 3,007.17 million in 2021, would rocket up to USD 4,650.17 million by 2029. Attenuated Live Vaccines dominates the product type segment of the companion animal vaccines market owing to the increasing development and launch of new vaccines and a robust pipeline and increasing personal disposable income. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview:
Companion animals vaccine are the vaccines that are given to the pets (dogs, cats and others) to stimulate their immune response. In other words, the companion animal vaccines are used to improve the functioning of immunity system in pets and other animals.
Some of the major players operating in the companion animal vaccines market are Elanco. (US), Boehringer Ingelheim International GmbH (Germany), Intervet Inc. (Germany), Zoetis Services LLC. (US), Bioveta, a.s. (Czechia), Sanofi (France), Bayer AG (Germany), Heska Corporation (US), Virbac. (France), Hester Biosciences Limited (India), Vetoquinol India Animal Health Pvt Ltd (India), Phibro Animal Health Corporation. (US), HIPRA (Spain), Novartis AG (Switzerland), Merck Sharp Dohme Corp. (Germany), Biovet Private Ltd (India) and Ceva (France) among others.
The companion animal vaccines market is analysed and market size insights and trends are provided by country, product type, species type, and distribution channel as referenced above.
The countries covered in the companion animal vaccines market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the companion animal vaccines market because of the strong base of healthcare facilities, rising adoption of companion pets by all aged people for eliminating psychological stress, increasing expenditure on veterinary care and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, governments of countries in this region are promoting pet ownership programs and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 04: Global Companion Animal Vaccines Market Sizing
Part 05: Global Companion Animal Vaccines Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Browse Trending Reports link:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475